Page last updated: 2024-09-05

sb 216763 and Pulmonary Hypertension

sb 216763 has been researched along with Pulmonary Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alapati, D; Chen, S; Hehre, D; Hummler, SC; Rong, M; Wu, S1

Other Studies

1 other study(ies) available for sb 216763 and Pulmonary Hypertension

ArticleYear
Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    American journal of respiratory cell and molecular biology, 2013, Volume: 48, Issue:5

    Topics: Airway Remodeling; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hyperoxia; Hypertension, Pulmonary; Indoles; Infant, Newborn; Injections, Intraperitoneal; Lung; Maleimides; Phosphorylation; Pneumonia; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA

2013